CaixaBank, S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96.2M Buy
183,918
+11,198
+6% +$5.73M 0.43% 52
2026
Q2
$85.8M Sell
172,720
-2,903
-2% -$1.29M 0.4% 59
2026
Q1
$78.4M Sell
175,623
-15,895
-8% -$7.41M 0.42% 55
2025
Q4
$86.8M Buy
191,518
+491
+0.3% +$212K 0.43% 53
2025
Q3
$74.8M Sell
191,027
-70,872
-27% -$29.6M 0.38% 59
2025
Q2
$117M Buy
261,899
+2,704
+1% +$1.25M 0.6% 44
2025
Q1
$126M Buy
259,195
+9,108
+4% +$4.24M 0.73% 39
2024
Q4
$101M Buy
250,087
+1,189
+0.5% +$551K 0.53% 51
2024
Q3
$116M Sell
248,898
-2,147
-0.9% -$1.03M 0.63% 40
2024
Q2
$118M Buy
251,045
+27,111
+12% +$11.8M 0.67% 40
2024
Q1
$93.6M Sell
223,934
-5,156
-2% -$2.18M 0.56% 50
2023
Q4
$93.2M Sell
229,090
-27,335
-11% -$10.1M 0.64% 45
2023
Q3
$89.2M Sell
256,425
-2,745
-1% -$960K 0.69% 42
2023
Q2
$91.2M Sell
259,170
-20,781
-7% -$7M 0.68% 42
2023
Q1
$88.2M Buy
279,951
+30,660
+12% +$9.2M 0.71% 39
2022
Q4
$72M Buy
249,291
+58,672
+31% +$17.9M 0.6% 50
2022
Q3
$55.2M Buy
190,619
+36,558
+24% +$10.5M 0.48% 54
2022
Q2
$43.4M Buy
154,061
+107,200
+229% +$28.7M 0.39% 67
2022
Q1
$12.2M Buy
46,861
+1,508
+3% +$358K 0.1% 142
2021
Q4
$10M Sell
45,353
-1,482
-3% -$288K 0.08% 179
2021
Q3
$8.5M Sell
46,835
-2,067
-4% -$404K 0.08% 179
2021
Q2
$9.9M Sell
48,902
-5,717
-10% -$1.2M 0.09% 150
2021
Q1
$11.7M Buy
54,619
+4,508
+9% +$990K 0.12% 134
2020
Q4
$11.8M Buy
50,111
+3,544
+8% +$813K 0.11% 158
2020
Q3
$12.7M Buy
46,567
+1,386
+3% +$382K 0.13% 142
2020
Q2
$13.1M Buy
45,181
+42,166
+1,399% +$11.4M 0.16% 128
2020
Q1
$717K Buy
+3,015
New +$692K 0.01% 242
2019
Q2
– Sell
-64,458
Closed -$11.8M – 383
2019
Q1
$11.8M Buy
64,458
+57,177
+785% +$10.6M 0.27% 101
2018
Q4
$1.18M Buy
7,281
+3,539
+95% +$613K 0.03% 196
2018
Q3
$644K Buy
3,742
+1,165
+45% +$207K 0.02% 218
2018
Q2
$438K Buy
2,577
+1,449
+128% +$225K 0.01% 214
2018
Q1
$184K Sell
1,128
-10
-0.9% -$1.63K 0.01% 257
2017
Q4
$171K Sell
1,138
-58
-5% -$8.59K 0.01% 255
2017
Q3
$182K Buy
+1,196
New +$180K 0.01% 236

Other funds holding VRTX

CaixaBank, S.A.'s VRTX Position: Q3 2026 in Review

CaixaBank, S.A. increased its Vertex Pharmaceuticals (VRTX) stake by 6.5% in Q3 2026, buying an estimated $5.73M and bringing the position to 183,918 shares worth $96.2M. The position accounts for 0.43% of the portfolio, ranked #52.

CaixaBank, S.A. first reported a position in VRTX in Q3 2017 and has held it in 34 quarters since. The position peaked at $126M in Q1 2025. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • CaixaBank, S.A. held 183,918 shares of Vertex Pharmaceuticals worth $96.2M as of Q3 2026.
  • CaixaBank, S.A. bought 11,198 Vertex Pharmaceuticals shares in Q3 2026, an estimated $5.73M.
  • Vertex Pharmaceuticals made up 0.43% of CaixaBank, S.A.'s portfolio in Q3 2026, its #52 holding.
  • CaixaBank, S.A. first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 34 quarters since.
  • CaixaBank, S.A.'s Vertex Pharmaceuticals position peaked at $126M in Q1 2025.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.